This is how original PR should been! Hehehe
$Soligenix (SNGX.US)$ Soligenix Announced That Analysis Of The Post-treatment Data From The Open-label Study Comparing HyBryte (Synthetic Hypericin) To Valchlor (Mechlorethamine) Has Demonstrated Continued Improvement In HyBryte-treated Patients And Their Individual Lesions Even After Stopping Treatment
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more